Concepedia

Marina Kovalenko

MK

Statistics

Publications

22

Citations

1.3K

H-Index

17

Active since

1994

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Broad Institute

Ludwig Cancer Research

Friedrich Schiller University Jena

Marina Kovalenko is an author at Massachusetts General Hospital specializing in life sciences, huntington disease, and neurodegenerative diseases.

ORCID

Publications per year

1994–2025

22

Publications

22

Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.

Marina Kovalenko, Aviv Gazit, Annette Böhmer et al. · PubMed · 1994 · 273 citations

, , +14

Site-selective Dephosphorylation of the Platelet-derived Growth Factor β-Receptor by the Receptor-like Protein-tyrosine Phosphatase DEP-1

Marina Kovalenko, Karsten Denner, Jill Sandström et al. · Journal of Biological Chemistry · 2000 · 150 citations · Full text

, , +17

Phosphorylation Site-Specific Inhibition of Platelet-Derived Growth Factor β-Receptor Autophosphorylation by the Receptor Blocking Tyrphostin AG1296

Marina Kovalenko, Lars Rönnstrand, Carl‐Henrik Heldin et al. · Biochemistry · 1997 · 127 citations

, , +16

Msh2 Acts in Medium-Spiny Striatal Neurons as an Enhancer of CAG Instability and Mutant Huntingtin Phenotypes in Huntington’s Disease Knock-In Mice

Marina Kovalenko, Ella Dragileva, Jason St. Claire et al. · PLoS ONE · 2012 · 95 citations · Full text

, , +17

Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington’s disease knock-in mice is blocked by Mlh1 knock-out

Jacob M. Loupe, Ricardo Mouro Pinto, Kyung‐Hee Kim et al. · Human Molecular Genetics · 2020 · 90 citations · Full text

, , +16

1–5 of 22